Skip to main content
Clinical Trials/NCT00078143
NCT00078143
Completed
Phase 3

Motivational Enhancement Therapy (MET) to Improve Treatment Utilization in Pregnant Substance Users

University of Cincinnati6 sites in 1 country200 target enrollmentOctober 2003

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Substance-Related Disorders
Sponsor
University of Cincinnati
Enrollment
200
Locations
6
Primary Endpoint
Treatment Utilization
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

The purpose of this study is to compare Motivational Enhancement Therapy (MET) with standard drug abuse treatment among pregnant women.

Registry
clinicaltrials.gov
Start Date
October 2003
End Date
April 2006
Last Updated
9 years ago
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • Pregnancy \<30 weeks
  • Have not attended drug treatment in past 28 days
  • Not needing residential treatment (except detox)
  • Not at risk for suicide/homicide
  • Have no pending legal charges (except drug treatment)

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Treatment Utilization

Substance Abuse

Study Sites (6)

Loading locations...

Similar Trials